Johnson Nathan B, Deck Kathryn M, Nizzi Christopher P, Eisenstein Richard S
From the Department of Nutritional Sciences, University of Wisconsin, Madison, Wisconsin 53706.
From the Department of Nutritional Sciences, University of Wisconsin, Madison, Wisconsin 53706
J Biol Chem. 2017 Sep 22;292(38):15976-15989. doi: 10.1074/jbc.M117.785741. Epub 2017 Aug 2.
Iron-regulatory protein 1 (IRP1) belongs to a family of RNA-binding proteins that modulate metazoan iron metabolism. Multiple mechanisms are employed to control the action of IRP1 in dictating changes in the uptake and metabolic fate of iron. Inactivation of IRP1 RNA binding by iron primarily involves insertion of a [4Fe-4S] cluster by the cytosolic iron-sulfur cluster assembly (CIA) system, converting it into cytosolic aconitase (c-acon), but can also involve iron-mediated degradation of IRP1 by the E3 ligase FBXL5 that also targets IRP2. How CIA and FBXL5 collaborate to maintain cellular iron homeostasis through IRP1 and other pathways is poorly understood. Because impaired Fe-S cluster biogenesis associates with human disease, we determined the importance of FBXL5 for regulating IRP1 when CIA is impaired. Suppression of FBXL5 expression coupled with induction of an IRP1 mutant (IRP1) that cannot insert the Fe-S cluster, or along with knockdown of the CIA factors NUBP2 or FAM96A, reduced cell viability. Iron supplementation reversed this growth defect and was associated with FBXL5-dependent polyubiquitination of IRP1. Phosphorylation of IRP1 at Ser-138 increased when CIA was inhibited and was required for iron rescue. Impaired CIA activity, as noted by reduced c-acon activity, was associated with enhanced FBXL5 expression and a concomitant reduction in IRP1 and IRP2 protein level and RNA-binding activity. Conversely, expression of either IRP induced FBXL5 protein level, demonstrating a negative feedback loop limiting excessive accumulation of iron-response element RNA-binding activity, whose disruption reduces cell growth. We conclude that a regulatory circuit involving FBXL5 and CIA acts through both IRPs to control iron metabolism and promote optimal cell growth.
铁调节蛋白1(IRP1)属于一类RNA结合蛋白家族,可调节后生动物的铁代谢。多种机制被用于控制IRP1在决定铁的摄取和代谢命运变化中的作用。铁对IRP1 RNA结合的失活主要涉及胞质铁硫簇组装(CIA)系统插入一个[4Fe-4S]簇,将其转化为胞质乌头酸酶(c-acon),但也可能涉及E3连接酶FBXL5介导的铁依赖性IRP1降解,FBXL5也靶向IRP2。目前对CIA和FBXL5如何通过IRP1和其他途径协同维持细胞铁稳态知之甚少。由于铁硫簇生物合成受损与人类疾病相关,我们确定了在CIA受损时FBXL5对调节IRP1的重要性。抑制FBXL5表达并诱导不能插入铁硫簇的IRP1突变体(IRP1),或与敲低CIA因子NUBP2或FAM96A一起,会降低细胞活力。补充铁可逆转这种生长缺陷,并与IRP1的FBXL5依赖性多聚泛素化有关。当CIA被抑制时,IRP1在Ser-138处的磷酸化增加,这是铁救援所必需的。如c-acon活性降低所示,CIA活性受损与FBXL5表达增强以及IRP1和IRP2蛋白水平及RNA结合活性的相应降低有关。相反,任一IRP的表达都会诱导FBXL5蛋白水平,表明存在一个负反馈回路,限制铁反应元件RNA结合活性的过度积累,其破坏会降低细胞生长。我们得出结论,一个涉及FBXL5和CIA的调节回路通过两个IRP起作用,以控制铁代谢并促进最佳细胞生长。